Arrowhead Pharmaceuticals (ARWR) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.39
-0.01
1.37
2.75

Details

Expected EPS
-0.952272
Actual EPS
-1.26
Surprise EPS
-0.31
Surprise Percent
+32.32%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.26 per share for Q3 2025.

0 Comments

Share your thoughts